ArticleBMC oral health2025
Evaluation of piezosurgery combined with L-PRF, A-PRF, and photobiomodulation for optimizing MRONJ treatment: an animal study.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This research evaluates the complementary roles of piezosurgery, photobiomodulation (PBM), leukocyte- and platelet-rich fibrin (L-PRF), and advanced platelet-rich fibrin (A-PRF) in the management of medication-related osteonecrosis of the jaw (MRONJ). First, we induced MRONJ lesions in rats. All rats were inspected for signs of MRONJ eight weeks post-extraction. Forty-nine rats having positive signs of MRONJ were selected and categorized into seven different groups: C (control), PS (piezosurgery), P (piezosurgery + PBM), A (piezosurgery + A-PRF), L (piezosurgery + L-PRF), A + P (piezosurgery + A-PRF + PBM), and L + P (piezosurgery + L-PRF + PBM). Thirty days after the last treatment session, euthanasia was carried out. Additionally, the healing of the lesions was evaluated radiographically, clinically, and histologically. The data were analyzed using STATA software version 14, with a significance level set at 5%. Based on the current research, L-PRF and A-PRF treatments led to significant improvements in radiographical, clinical, and histological parameters compared to the C group (P ˂ 0.05). The PBM, compared to the C group (P ˂ 0.05), decreased the number of empty lacunae and bone and wound exposure dimensions. 6 out of 7 cases showed complete MRONJ resolution in L + P and A + P (P ˂ 0.05). Consequently, no considerable difference between A-PRF and L-PRF treatment groups was observed (P ˃ 0.05). Considering the limitations of this animal study, we concluded that piezosurgery and photobiomodulation alone, unlike PRF, are insufficient for MRONJ treatment. Importantly, the combination of piezosurgery, PBM, and PRF therapy yielded the most promising results in addressing MRONJ. Further clinical investigations are required to confirm these findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.